Yes thar was too quick and designed to pass. Around the time they were starting up phase 3 clinical trials in november on 40k patients the final report about pre-clinical animal model trials were published (confidential ofc) and it showed a host of safety signals going off everywhere.

Reply to this note

Please Login to reply.

Discussion

No replies yet.